News

Find out what’s hitting the headlines in our pioneering dementia research and how your support is bringing us closer to a cure.

If you have a press enquiry please visit our Press Office page.

Posted on 18 Jul

Number of pregnancies linked to Alzheimer’s risk

American Academy of Neurology: Differential effects of completed and incomplete pregnancies on the risk of Alzheimer disease A new study by researchers in Korea and the US suggests a link between number of pregnancies and the risk of Alzheimer’s disease. The research is published today (Wednesday 18 July) in the Journal of The American Academy […]

Read more

Posted on 11 Jul

High blood pressure later in life linked to Alzheimer’s risk

Journal of Neurology: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology A new study by researchers in the US suggests that having high blood pressure later in life may affect the brain, resulting in brain diseases such as Alzheimer’s disease. The research is published today (Wednesday 11 July) in the Journal of The […]

Read more

Posted on 04 Jul

10,000 research participants recruited through innovative service – Join Dementia Research

Latest stats, released today, show that 10,000 study participants have been involved in vital dementia research thanks to an innovative service run by the National Institute for Health Research (NIHR). This news comes in the wake of new guidance released by NICE in June 2018, encouraging health and care professionals to inform people with dementia about […]

Read more

Posted on 02 Jul

Low dose of aspirin reduces Alzheimer’s protein amyloid in mice

JNeurosci: Aspirin induces Lysosomal biogenesis and attenuates Amyloid plaque pathology in a mouse model of Alzheimer’s disease via PPARα Scientists in the US have found that a low dose of aspirin reduces the hallmark Alzheimer’s protein, amyloid, in the brains of mice with features of the disease. The findings are published today (Monday 2 July) […]

Read more

Posted on 27 Jun

Genes linking Alzheimer’s and Down syndrome discovered

Scientists are a step closer to understanding which genes are responsible for early onset Alzheimer’s disease in people with Down syndrome, thanks to a new study led by researchers at the Francis Crick Institute and UCL along with an international group of collaborators. The findings could pave the way for future medicines to prevent the […]

Read more

Posted on 21 Jun

Forms of herpes virus associated with Alzheimer’s disease

Neuron: Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, genetic, and Clinical Networks by Human Herpesvirus Scientists in the US have found an association between two forms of the human herpes virus and Alzheimer’s disease. The findings are published today (Thursday 21 June) in the scientific journal Neuron. Dr David Reynolds, Chief Scientific […]

Read more

Posted on 19 Jun

Dementia researchers in Leeds to share findings with the public

Researchers in Leeds are inviting members of the public to a free public meeting being held on Thursday 28 June from 3:00-5:30pm. The meeting will involve talks from scientists at the forefront of research into dementia. The public event is organised by members of the Alzheimer’s Research UK Yorkshire Network Centre. Alzheimer’s Research UK is […]

Read more

Posted on 18 Jun

East Anglian trust’s £5 million boost to Cambridge dementia drug discovery

The ALBORADA Trust has generously pledged £5million to Cambridgeshire-based national charity Alzheimer’s Research UK to support five years of pioneering drug discovery research through the ALBORADA Drug Discovery Institute at the University of Cambridge. The pledge is both the largest commitment ever made by The ALBORADA Trust and the largest ever received by the charity. […]

Read more

Posted on 14 Jun

Dementia researchers to share findings with public in Bristol

Researchers in Bristol are inviting members of the public to a free dementia information event on Tuesday 26 June from 6:30-9:00pm. The meeting will involve talks from scientists at the forefront of research into the condition and an opportunity for attendees to put their questions to the experts. The public event is organised by members […]

Read more

Posted on 13 Jun

Setback for Alzheimer’s drug in final-stage trial

Eli Lilly and AstraZeneca have announced that they are ending two trials of the experimental Alzheimer’s drug lanebecestat. The announcement comes after an analysis indicated the drug was unlikely to meet the aims of the trial. Lanebecestat belongs to a class of drugs known as BACE inhibitors which are designed to reduce the build-up of […]

Read more

1 2 3 50